Can-Fite BioPharma Ltd.
CANF
$0.53
-$0.04-6.81%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -23.22% | -23.22% | -- | -- | -- |
| Total Depreciation and Amortization | 2,200.00% | 2,200.00% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.97% | -12.97% | -- | -- | -- |
| Change in Net Operating Assets | 50.89% | 50.89% | -- | -- | -- |
| Cash from Operations | -17.74% | -17.74% | -- | -- | -- |
| Capital Expenditure | 75.00% | 75.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33.33% | -33.33% | -- | -- | -- |
| Cash from Investing | -33.30% | -33.30% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 147.37% | 147.37% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 269.39% | 269.39% | -- | -- | -- |